Detalles de la búsqueda
1.
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic.
Crit Care Med
; 51(4): 445-459, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36790189
2.
Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use.
J Antimicrob Chemother
; 77(5): 1396-1403, 2022 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194648
3.
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
J Infect Dis
; 222(8): 1334-1344, 2020 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32406487
4.
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy.
J Infect Dis
; 222(4): 601-610, 2020 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32201883
5.
Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir.
J Antimicrob Chemother
; 75(11): 3303-3310, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32766700
6.
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Br J Clin Pharmacol
; 86(1): 132-142, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31656054
7.
Don't Put Off Until Tomorrow What You Can Do Today: Hospital Admissions as an Opportunity to Treat Hepatitis C.
Clin Infect Dis
; 78(3): 591-593, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991385
8.
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
J Viral Hepat
; 26(3): 337-349, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30421537
9.
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.
Hepatology
; 67(2): 514-523, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926120
10.
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
Clin Infect Dis
; 67(7): 1010-1017, 2018 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29566246
11.
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
N Engl J Med
; 373(8): 714-25, 2015 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26196502
13.
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
Hepatology
; 66(6): 1794-1804, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28688129
14.
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
J Infect Dis
; 215(4): 599-605, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28329334
15.
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
Clin Infect Dis
; 65(1): 6-12, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28369210
16.
Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir.
J Hepatol
; 66(4): 703-710, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27923693
17.
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.
J Hepatol
; 67(2): 263-271, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28412293
18.
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
Gastroenterology
; 151(4): 651-659.e1, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27456384
19.
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
Liver Int
; 37(12): 1796-1804, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28470938
20.
Resistance to DAAs: When to Look and When It Matters.
Curr HIV/AIDS Rep
; 14(6): 229-237, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29116550